Physicians have long been concerned that patients with multiple sclerosis who get frequent brain scans accumulate deposits of the rare earth used as a contrast agent, gadolinium. German researchers found an alternative agent.
Patients with multiple sclerosis may have excess iron in their brains, a possible explanation for brain atrophy, the debilitating condition some develop. If so, the culprit is likely leaky red blood cells, a UK team reported.
Cornell scientists said they created a chemical tool that uses ultraviolet light to track inflammation and even control it. Their hope is it might work to treat inflammatory diseases, perhaps even multiple sclerosis.